{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T02:01:29Z","timestamp":1780020089423,"version":"3.53.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100021110","name":"Dayananda Sagar University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100021110","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47067-8","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:16:12Z","timestamp":1775736972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Continuous glucose monitoring-based evaluation of percentage coefficient of variation (%CV) as a metric of intraday glycemic variability in South India"],"prefix":"10.1038","volume":"16","author":[{"given":"Mohammed Azhar","family":"Hussain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Kumar H","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2152-8627","authenticated-orcid":false,"given":"Mahadevamma","family":"Lingaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"47067_CR1","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.2337\/dc18-1581","volume":"41","author":"RM Bergenstal","year":"2018","unstructured":"Bergenstal, R. M. et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care. 41, 2275\u20132280 (2018).","journal-title":"Diabetes Care"},{"key":"47067_CR2","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s00125-007-0803-0","volume":"50","author":"DM Nathan","year":"2007","unstructured":"Nathan, D. M., Turgeon, H. & Regan, S. Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia 50, 2239\u20132244 (2007).","journal-title":"Diabetologia"},{"key":"47067_CR3","doi-asserted-by":"publisher","first-page":"994","DOI":"10.2337\/dc17-0636","volume":"40","author":"RW Beck","year":"2017","unstructured":"Beck, R. W., Connor, C. G., Mullen, D. M., Wesley, D. M. & Bergenstal, R. M. The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading. Diabetes Care. 40, 994\u2013999 (2017).","journal-title":"Diabetes Care"},{"key":"47067_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/diagnostics3040385","volume":"3","author":"SK Vashist","year":"2013","unstructured":"Vashist, S. K. Continuous Glucose Monitoring Systems: A Review. Diagnostics (Basel). 3, 385\u2013412 (2013).","journal-title":"Diagnostics (Basel)"},{"key":"47067_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.4093\/dmj.2019.0121","volume":"43","author":"G Cappon","year":"2019","unstructured":"Cappon, G., Vettoretti, M., Sparacino, G. & Facchinetti, A. Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications. Diabetes Metab. J. 43, 383\u2013397 (2019).","journal-title":"Diabetes Metab. J."},{"key":"47067_CR6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/dom.14906","volume":"25","author":"D Rodbard","year":"2023","unstructured":"Rodbard, D. Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy. Diabetes Obes. Metab. 25, 596\u2013601 (2023).","journal-title":"Diabetes Obes. Metab."},{"key":"47067_CR7","doi-asserted-by":"publisher","first-page":"e001052","DOI":"10.1136\/bmjdrc-2019-001052","volume":"8","author":"F Gomez-Peralta","year":"2020","unstructured":"Gomez-Peralta, F., Dunn, T., Landuyt, K., Xu, Y. & Merino-Torres, J. F. Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain. BMJ Open. Diabetes Res. Care. 8, e001052 (2020).","journal-title":"BMJ Open. Diabetes Res. Care"},{"key":"47067_CR8","doi-asserted-by":"publisher","first-page":"102509","DOI":"10.1016\/j.dsx.2022.102509","volume":"16","author":"DB Duarte","year":"2022","unstructured":"Duarte, D. B. et al. Impact of intermittently scanned continuous glucose monitoring on quality of life and glycaemic control in persons with type 1 diabetes: A 12-month follow-up study in real life. Diabetes Metab. Syndr. 16, 102509 (2022).","journal-title":"Diabetes Metab. Syndr."},{"key":"47067_CR9","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1111\/dom.13842","volume":"21","author":"EG Wilmot","year":"2019","unstructured":"Wilmot, E. G., Choudhary, P., Leelarathna, L. & Baxter, M. Glycaemic variability: The under-recognized therapeutic target in type 1 diabetes care. Diabetes Obes. Metab. 21, 2599\u20132608 (2019).","journal-title":"Diabetes Obes. Metab."},{"key":"47067_CR10","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2337\/db08-0063","volume":"57","author":"A Ceriello","year":"2008","unstructured":"Ceriello, A. et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 57, 1349\u20131354 (2008).","journal-title":"Diabetes"},{"key":"47067_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.diabres.2014.06.007","volume":"105","author":"J Smith-Palmer","year":"2014","unstructured":"Smith-Palmer, J. et al. Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes. Diabetes Res. Clin. Pract. 105, 273\u2013284 (2014).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"47067_CR12","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2337\/dc09-2082","volume":"33","author":"CV Desouza","year":"2010","unstructured":"Desouza, C. V., Bolli, G. B. & Fonseca, V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care. 33, 1389\u20131394 (2010).","journal-title":"Diabetes Care"},{"key":"47067_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.dsx.2018.08.028","volume":"13","author":"L Ferreira","year":"2019","unstructured":"Ferreira, L. et al. The impact of glycemic variability on length of stay and mortality in diabetic patients admitted with community-acquired pneumonia or chronic obstructive pulmonary disease. Diabetes Metab. Syndr. 13, 149\u2013153 (2019).","journal-title":"Diabetes Metab. Syndr."},{"key":"47067_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1507\/endocrj.K10E-378","volume":"58","author":"SK Kim","year":"2011","unstructured":"Kim, S. K. et al. Three-day continuous glucose monitoring for rapid assessment of hypoglycemic events and glycemic variability in type 1 diabetic patients. Endocr. J. 58, 535\u2013541 (2011).","journal-title":"Endocr. J."},{"key":"47067_CR15","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1007\/s00125-007-0820-z","volume":"50","author":"ES Kilpatrick","year":"2007","unstructured":"Kilpatrick, E. S., Rigby, A. S., Goode, K. & Atkin, S. L. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. Diabetologia 50, 2553\u20132561 (2007).","journal-title":"Diabetologia"},{"key":"47067_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2337\/cd20-0042","volume":"38","author":"EE Wright","year":"2020","unstructured":"Wright, E. E., Morgan, K., Fu, D. K., Wilkins, N. & Guffey, W. J. Time in Range: How to Measure It, How to Report It, and Its Practical Application in Clinical Decision-Making. Clin. Diabetes. 38, 439\u2013448 (2020).","journal-title":"Clin. Diabetes"},{"key":"47067_CR17","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2337\/dc17-1600","volume":"40","author":"T Danne","year":"2017","unstructured":"Danne, T. et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 40, 1631\u20131640 (2017).","journal-title":"Diabetes Care"},{"key":"47067_CR18","doi-asserted-by":"publisher","first-page":"832","DOI":"10.2337\/dc16-1769","volume":"40","author":"L Monnier","year":"2017","unstructured":"Monnier, L. et al. Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes. Diabetes Care. 40, 832\u2013838 (2017).","journal-title":"Diabetes Care"},{"key":"47067_CR19","first-page":"1332","volume":"27","author":"D Kapoor","year":"2018","unstructured":"Kapoor, D. et al. Association of dietary patterns and dietary diversity with cardiometabolic disease risk factors among adults in South Asia: The CARRS study. Asia Pac. J. Clin. Nutr. 27, 1332\u20131343 (2018).","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"47067_CR20","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1017\/S1368980017000416","volume":"20","author":"EJ Joy","year":"2017","unstructured":"Joy, E. J. et al. Dietary patterns and non-communicable disease risk in Indian adults: secondary analysis of Indian Migration Study data. Public. Health Nutr. 20, 1963\u20131972 (2017).","journal-title":"Public. Health Nutr."},{"key":"47067_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/jdi.14347","volume":"16","author":"M Shimizu","year":"2024","unstructured":"Shimizu, M. et al. Cross-sectional association of irregular dietary habits with glycemic control and body mass index among people with diabetes. J. Diabetes Invest. 16, 285 (2024).","journal-title":"J. Diabetes Invest."},{"key":"47067_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/jdi.13619","volume":"13","author":"M Umphonsathien","year":"2021","unstructured":"Umphonsathien, M. et al. Effects of intermittent very-low calorie diet on glycemic control and cardiovascular risk factors in obese patients with type 2 diabetes mellitus: A randomized controlled trial. J. Diabetes Invest. 13, 156 (2021).","journal-title":"J. Diabetes Invest."},{"key":"47067_CR23","doi-asserted-by":"publisher","first-page":"215013271988063","DOI":"10.1177\/2150132719880638","volume":"10","author":"V Samya","year":"2019","unstructured":"Samya, V. et al. Prevalence of Hypoglycemia Among Patients With Type 2 Diabetes Mellitus in a Rural Health Center in South India. J. Prim. Care Community Health. 10, 2150132719880638 (2019).","journal-title":"J. Prim. Care Community Health"},{"key":"47067_CR24","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1177\/19322968251333441","volume":"19","author":"JK Mader","year":"2025","unstructured":"Mader, J. K. et al. The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes. J. Diabetes Sci. Technol. 19, 1109\u20131127 (2025).","journal-title":"J. Diabetes Sci. Technol."},{"key":"47067_CR25","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1210\/clinem\/dgae379","volume":"110","author":"E Montaser","year":"2024","unstructured":"Montaser, E., Farhy, L. S. & Kovatchev, B. P. Novel Detection and Progression Markers for Diabetes Based on Continuous Glucose Monitoring Data Dynamics. J. Clin. Endocrinol. Metab. 110, 254\u2013262 (2024).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"47067_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1089\/dia.2024.0496","volume":"27","author":"E Montaser","year":"2025","unstructured":"Montaser, E., Farhy, L. S. & Rich, S. S. Enhancing Type 1 Diabetes Immunological Risk Prediction with Continuous Glucose Monitoring and Genetic Profiling. Diabetes Technol. Ther. 27, 292\u2013300 (2025).","journal-title":"Diabetes Technol. Ther."},{"key":"47067_CR27","unstructured":"FreeStyle Libre Pro. - FreeStyle Libre | Abbott. https:\/\/www.freestyle.abbott\/in-en\/libre-pro.html."},{"key":"47067_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.numecd.2018.01.003","volume":"28","author":"F Boscari","year":"2018","unstructured":"Boscari, F. et al. Head-to-head comparison of the accuracy of Abbott FreeStyle Libre and Dexcom G5 mobile. Nutr. Metab. Cardiovasc. Dis. 28, 425\u2013427 (2018).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"47067_CR29","volume-title":"Endotext","author":"N Reddy","year":"2000","unstructured":"Reddy, N., Verma, N. & Dungan, K. Monitoring Technologies- Continuous Glucose Monitoring, Mobile Technology, Biomarkers of Glycemic Control. in Endotext (ed (eds Feingold, K. R. et al.) (MDText.com, Inc., South Dartmouth (MA), (2000)."},{"key":"47067_CR30","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino, T. et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations From the international consensus on time in range. Diabetes Care. 42, 1593\u20131603 (2019).","journal-title":"Diabetes Care"},{"key":"47067_CR31","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes\u20142024. Diabetes Care 47, S111\u2013S125 (2023).","DOI":"10.2337\/dc24-S006"},{"key":"47067_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.16098","volume":"26","author":"RA Ajjan","year":"2024","unstructured":"Ajjan, R. A. The clinical importance of measuring glycaemic variability: Utilising new metrics to optimise glycaemic control. Diabetes Obes. Metab. 26, 3\u201316 (2024).","journal-title":"Diabetes Obes. Metab."},{"key":"47067_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jjcc.2021.08.009","volume":"79","author":"K Tateishi","year":"2022","unstructured":"Tateishi, K., Saito, Y., Kitahara, H. & Kobayashi, Y. Impact of glycemic variability on coronary and peripheral endothelial dysfunction in patients with coronary artery disease. J. Cardiol. 79, 65\u201370 (2022).","journal-title":"J. Cardiol."},{"key":"47067_CR34","first-page":"570","volume":"65","author":"T Valente","year":"2021","unstructured":"Valente, T. et al. Relationship between short and long-term glycemic variability and oxidative stress in type 1 diabetes mellitus under daily life insulin treatment. Arch. Endocrinol. Metab. 65, 570\u2013578 (2021).","journal-title":"Arch. Endocrinol. Metab."},{"key":"47067_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.diabres.2018.01.031","volume":"144","author":"R Rodrigues","year":"2018","unstructured":"Rodrigues, R. et al. Correlations of the glycemic variability with oxidative stress and erythrocytes membrane stability in patients with type 1 diabetes under intensive treatment. Diabetes Res. Clin. Pract. 144, 153\u2013160 (2018).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"47067_CR36","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.3390\/jcm14072434","volume":"14","author":"S Lazar","year":"2025","unstructured":"Lazar, S. et al. Glycemic Variability and Its Association with Traditional Glycemic Control Biomarkers in Patients with Type 1 Diabetes: A Cross-Sectional, Multicenter Study. J. Clin. Med. 14, 2434 (2025).","journal-title":"J. Clin. Med."},{"key":"47067_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s13300-017-0340-x","volume":"9","author":"SR Jangam","year":"2018","unstructured":"Jangam, S. R., Hayter, G. & Dunn, T. C. Individuals with Type 1 and Type 2 Diabetes Mellitus Trade Increased Hyperglycemia for Decreased Hypoglycemia When Glycemic Variability is not Improved. Diabetes Ther. 9, 395\u2013402 (2018).","journal-title":"Diabetes Ther."},{"key":"47067_CR38","doi-asserted-by":"publisher","first-page":"8393","DOI":"10.3390\/ijms22168393","volume":"22","author":"V Alfieri","year":"2021","unstructured":"Alfieri, V. et al. The Role of Glycemic Variability in Cardiovascular Disorders. Int. J. Mol. Sci. 22, 8393 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"47067_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1177\/1932296815601440","volume":"10","author":"M Reddy","year":"2015","unstructured":"Reddy, M. et al. Glycemic Variability and Its Impact on Quality of Life in Adults With Type 1 Diabetes. J. Diabetes Sci. Technol. 10, 60\u201366 (2015).","journal-title":"J. Diabetes Sci. Technol."},{"key":"47067_CR40","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00592-024-02241-0","volume":"61","author":"L Zhang","year":"2024","unstructured":"Zhang, L., Sun, X. X. & Tian, Q. S. Research progress on the association between glycemic variability index derived from CGM and cardiovascular disease complications. Acta Diabetol. 61, 679\u2013692 (2024).","journal-title":"Acta Diabetol."},{"key":"47067_CR41","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/jdi.13453","volume":"12","author":"Y Mo","year":"2021","unstructured":"Mo, Y. et al. Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetes. J. Diabetes Investig. 12, 1025\u20131034 (2021).","journal-title":"J. Diabetes Investig"},{"key":"47067_CR42","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1111\/jdi.14303","volume":"15","author":"T Urakami","year":"2024","unstructured":"Urakami, T. et al. Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes. J. Diabetes Investig. 15, 1669\u20131674 (2024).","journal-title":"J. Diabetes Investig"},{"key":"47067_CR43","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/jdi.13426","volume":"12","author":"A Miya","year":"2021","unstructured":"Miya, A. et al. Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment. J. Diabetes Investig. 12, 738\u2013746 (2021).","journal-title":"J. Diabetes Investig"},{"key":"47067_CR44","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1089\/dia.2019.0075","volume":"21","author":"AM G\u00f3mez","year":"2019","unstructured":"G\u00f3mez, A. M. et al. Defining High Glycemic Variability in Type 1 Diabetes: Comparison of Multiple Indexes to Identify Patients at Risk of Hypoglycemia. Diabetes Technol. Ther. 21, 430\u2013439 (2019).","journal-title":"Diabetes Technol. Ther."},{"key":"47067_CR45","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1038\/s41591-025-03949-4","volume":"31","author":"RM Anjana","year":"2025","unstructured":"Anjana, R. M. et al. Dietary profiles and associated metabolic risk factors in India from the ICMR\u2013INDIAB survey-21. Nat. Med. 31, 3813\u20133824 (2025).","journal-title":"Nat. Med."},{"key":"47067_CR46","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4103\/0971-5916.193297","volume":"144","author":"N Sowmya","year":"2016","unstructured":"Sowmya, N. et al. Comparison of dietary profile of a rural south Indian population with the current dietary recommendations for prevention of non-communicable diseases (CURES 147). Indian J. Med. Res. 144, 112\u2013119 (2016).","journal-title":"Indian J. Med. Res."},{"key":"47067_CR47","first-page":"237","volume":"14","author":"V Mohan","year":"2023","unstructured":"Mohan, V. et al. Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian Perspective. Diabetes Ther. 14, 237\u2013249 (2023).","journal-title":"Diabetes Ther."},{"key":"47067_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/17843286.2025.2528030","volume":"80","author":"P Oriot","year":"2025","unstructured":"Oriot, P. et al. Short-term CGM as a tool to optimize glycemic control and defer intensive insulin therapy in people with poorly controlled type 2 diabetes: a Belgian real-life study. Acta Clin. Belg. 80, 71\u201382 (2025).","journal-title":"Acta Clin. Belg."},{"key":"47067_CR49","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12933-020-01085-6","volume":"19","author":"Z Zhou","year":"2020","unstructured":"Zhou, Z., Sun, B., Huang, S., Zhu, C. & Bian, M. Glycemic variability: adverse clinical outcomes and how to improve it? Cardiovasc. Diabetol. 19, 102 (2020).","journal-title":"Cardiovasc. Diabetol."},{"key":"47067_CR50","doi-asserted-by":"publisher","first-page":"112961","DOI":"10.1016\/j.diabres.2025.112961","volume":"230","author":"SA Jahed","year":"2025","unstructured":"Jahed, S. A. et al. The use of continuous glucose monitoring in outpatient diabetes care: Iranian expert consensus statement. Diabetes Res. Clin. Pract. 230, 112961 (2025).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"47067_CR51","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2337\/dc25-2353","volume":"49","author":"E Montaser","year":"2026","unstructured":"Montaser, E., Williams, C. & Shah, V. N. Assessing Time Below Range as a Predictor of Severe Hypoglycemia: Insights From Six Clinical Trials. Diabetes Care. 49, 483\u2013489 (2026).","journal-title":"Diabetes Care"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47067-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47067-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47067-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T01:01:55Z","timestamp":1780016515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47067-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47067"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47067-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Institutional Ethics Committee of CDSIMER (Ref- No. CDSIMER\/MR\/0104\/IEC2023, dated 26-12-2023) and conducted in accordance with the declaration of Helsinki. Written informed consent was obtained from all participants prior to inclusion.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval<!--Emphasis Type='Bold' removed-->and informed consent"}},{"value":"During the preparation of this manuscript, the authors used AI tools like ChatGPT to improve the language and readability. After using this tool, the authors reviewed and edited the content as needed and took full responsibility for the publication\u2019s content.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Declaration of use of AI and AI-assisted technologies"}}],"article-number":"16657"}}